Urinary Free Cortisol Determinations: What They Measure

Authors:
  • BMBeverley E. Pearson Murphy
    Beverley E. Pearson Murphy

Abstract
With the introduction of competitive protein-binding (CPB) methods, clinically useful assays for unconjugated cortisol in urine (urinary free cortisol [UFC]) have been available since 1968 and have been widely used to assess adrenocortical function. The initial method used human corticosteroid-binding globulin in a radiotransinassay, which was extensively validated clinically. Most assays developed later made use of antibodies raised to steroids conjugated to albumin and were assumed to provide similar results. During 1980 and 1981, using detailed chromatography to increase specificity, it became apparent that the true average cortisol level in adults was approximately 60 nmol/day: one-half or less than that measured by commercially available kits. Although the presence of interfering substances was clearly shown, the same direct assays have continued to be used to the present, so that almost all the data for UFC in the literature are two-times to four-times higher than the true values. The interfering substances in each assay have not been defined, so that the relevance of such data is questionable. Why has such a situation persisted? Factors perpetuating this situation include: commercial kit manufacturers who have continued to market the same assays without validating them properly, journals that continue to accept data that are clearly too high, textbooks that seemingly have not kept up with the literature, and clinical laboratories that are reluctant to cover the increased cost of performing accurate assays. The wide recognition of this unsatisfactory situation may provide a stimulus to the development of cheaper and more accurate UFC assays, which are feasible with current technology.

This publication has 32 references indexed in Scilit: